[April 21, 2005] IntraLase Schedules First-Quarter Conference Call for Thursday, April 28, 2005 Tweet IRVINE, Calif. --(Business Wire)-- April 21, 2005 -- IntraLase Corp. (Nasdaq:ILSE) announced today that it will report its 2005 first-quarter results on Thursday, April 28, 2005. A news release will be distributed over Business Wire and will also be posted on the company's web site: www.intralase.com. Also on April 28, IntraLase will hold an investor conference call at 11:00 a.m. Eastern Time to discuss the company's results. Hosting the call will be Robert J. Palmisano, President and Chief Executive Officer, and Shelley B. Thunen, Executive Vice President and Chief Financial Officer. The conference call will be webcast live by Thomson/CCBN and can be accessed on the IntraLase web site. A recorded version of the webcast will be available for a one-week period following the call. The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at: www.fulldisclosure.com. Institutional investors can access the call via the password-protected event management site, StreetEvents www.streetevents.com. The call may also be accessed by telephone at 800-299-0433 or for international parties at 617-801-9712 and entering the confirmation code 60005462 between 10:50 a.m. and 11:00 a.m. Eastern Time. A telephone rebroadcast of the call may be accessed April 28, 2005 by 1:00 p.m. Eastern Time for a one-week period by calling 888-286-8010 or for international parties 617-801-6888 and entering confirmation code 11103955. About IntraLase Corp: IntraLase designs, develops and manufactures an ultra-fast laser, related software and disposable devices used to create a corneal flap, the first step in LASIK surgery for the correction of vision. The company's products improve the safety, precision and visual results of LASIK procedures by providing a computer-controlled laser solution in place of the hand-held mechanical, metal-bladed microkeratome traditionally used to create corneal flaps. IntraLase lasers are also used in surgical approaches to the treatment of diseased corneas. The company's lasers and disposable per procedure patient interfaces are presently marketed throughout the United States and 19 other countries. IntraLase is headquartered and manufactures its products in Irvine, Calif. For additional information, visit the company's web site: www.intralase.com. [ Back To TMCnet.com's Homepage ]